Sign in

CIK 0001661998

  • Non-accelerated filer
  • Smaller reporting company

Q32 Bio Inc.

Sign in to watch
Ticker
QTTB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473468154
Phone
+1 781-999-0232
Business address
830 WINTER STREET, WALTHAM, MA, 02451
Former names
Q32 Bio Inc., Homology Medicines, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$320,396
in 6 filings

Net −$320,396. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-07-01 Smith W Bradford CFO, Treasurer & Secretary Sale −6,000 $19.00 $114K 0
2019-07-01 Smith W Bradford CFO, Treasurer & Secretary Exercise or conversion · Employee Stock Option −6,000 151,404
2019-07-01 TZIANABOS ARTHUR President & CEO Sale −12,500 $18.98 $237K 165,005
2019-06-06 Flynn James E Director Grant or award · Stock Option (Right to Buy) +15,580 15,580
2019-06-06 Wheeler Cameron Director Grant or award · Option (Right to Buy) +15,580 15,580
2019-06-06 Gregory Richard J. Director Grant or award · Option (Right to Buy) +15,580 15,580
2019-06-06 Wheeler Cameron Director Grant or award · Option (Right to Buy) +15,580 15,580
2019-06-06 Thistle Mary Director Grant or award · Option (Right to Buy) +15,580 15,580
2019-06-06 Patterson Matthew R Director Grant or award · Option (Right to Buy) +15,580 15,580
2019-06-06 PARMAR KUSH Director Grant or award · Option (Right to Buy) +15,580 15,580
2019-06-06 GILLIS STEVEN Director Grant or award · Option (Right to Buy) +15,580 15,580
2019-06-03 Smith W Bradford CFO, Treasurer & Secretary Exercise or conversion +6,000 $0.64 $4K 6,000
2019-06-03 Smith W Bradford CFO, Treasurer & Secretary Sale −6,000 $19.94 $120K 0
2019-06-03 Smith W Bradford CFO, Treasurer & Secretary Exercise or conversion · Employee Stock Option −6,000 157,404
2019-06-03 Kelly Timothy P Sale −1,288 $20.00 $26K 0
2019-06-03 Seymour Albert Chief Scientific Officer Sale −9,300 $19.90 $185K 218,950
2019-06-03 TZIANABOS ARTHUR President & CEO Sale −12,500 $19.86 $248K 177,505
2019-06-03 Rasty Siyamak Chief Operating Officer Sale −8,000 $20.22 $162K 230,707
2019-05-21 ARCH Venture Fund VIII, L.P. 10% owner Other disposition −300,001 5,768,694
2019-05-16 5AM Ventures IV, L.P. 10% owner Sale −590,400 $21.47 $12.7M 5,314,484

Page 21 of 25 · 492 trades